![]() |
市場調查報告書
商品編碼
1859796
全球荷爾蒙平衡補充市場:預測(至2032年)-按成分類型、產品形式、消費者群體、通路和地區分類的分析Hormonal Balance Supplements Market Forecasts to 2032 - Global Analysis By Ingredient Type, Product Form, Consumer Group, Distribution Channel, and By Geography |
||||||
據 Stratistics MRC 稱,全球荷爾蒙平衡補充劑市場預計到 2025 年將達到 38 億美元,到 2032 年將達到 67 億美元,預測期內複合年成長率為 8.1%。
荷爾蒙平衡補充劑採用植物萃取物、適應原、維生素、礦物質和臨床研究的化合物配製而成,旨在支持內分泌功能、生殖健康、壓力反應和代謝調節。目標消費者尋求一種無需處方箋、以生活方式為導向的症狀管理和長期健康維護方法。市場擴張的促進因素包括健康意識的提高、人口結構的變化以及內分泌問題篩檢的增加。
據梅奧診所稱,消費者使用包括植物雌激素產品在內的荷爾蒙平衡補充劑的情況正在增加,美國有 11% 的成年女性表示正在使用補充劑來緩解更年期症狀或補充荷爾蒙。
人們對荷爾蒙健康的認知不斷提高
荷爾蒙健康意識的提升:大眾對荷爾蒙健康的日益關注推動了對調節月經平衡、緩解更年期症狀、支持甲狀腺功能和改善腎上腺疲勞等保健品的需求。受社群媒體、意見領袖和便利健康資訊的影響,消費者正在尋求預防和治療方案。醫療保健專業人員推薦針對性膳食補充劑,而配方師則致力於開發基於實證醫學的配方和個人化劑量方案。零售通路的拓展、訂閱模式的改進以及更清晰的標籤標識提高了產品的可及性和可信度,而臨床研究和品質保證體系的完善則極大地增強了消費者的信心,從而支撐了不同人群和配銷通路的市場穩步成長。
缺乏強而有力的臨床證據
缺乏強力的臨床證據:由於缺乏嚴格的臨床試驗和標準化的劑量指南,醫療保健專業人員對荷爾蒙補充劑的推薦以及醫療機構的採購受到限制。許多產品依賴傳統用法和小規模研究,導致其在不同族群中的療效和安全性存在不確定性。這些科學上的不足阻礙了保險覆蓋和大規模臨床應用,而監管機構則要求更高的證據標準。因此,消費者的懷疑態度和零售商謹慎的商品上架做法減緩了市場滲透率。
進軍男性健康領域
進軍男性健康領域:針對男性荷爾蒙健康,市場前景廣闊,能夠有效解決男性對睪固酮平衡、性慾和老齡化相關代謝等方面的擔憂。隨著越來越多的男性尋求預防性健康產品和個人化方案,該領域正在不斷擴張。針對男性生理特徵的臨床訊息、隱藏的行銷管道以及膠囊和軟糖等男性專用配方,正在提升市場接受度。與泌尿系統、健身專家以及職場健康計畫的夥伴關係,能夠有效推動產品普及。此外,公眾意識的提高和人口結構的變化也將推動長期需求成長,並實現收入來源多元化。
仿冒品品
仿冒品偽劣產品:仿冒品、摻假或不合格保健品的氾濫,損害了合法市場的發展,削弱了消費者的信任,並帶來健康風險。低劣的成分、錯誤標示和不一致的生產流程都可能導致不利事件、產品召回和法律訴訟,從而損害品牌聲譽。零售商可能會收緊產品上架標準,監管機構也可能加強監管,增加合規成本。
疫情期間,消費者尋求增強免疫力和緩解壓力,導致保健品需求激增,激素類保健品銷售一度飆升。供應鏈中斷造成短期原料短缺,並促使籌資策略轉變,同時,供應中斷也推動了電商和直銷模式的發展。臨床研究放緩,但人們對預防性保健的關注度卻有所提升,促使生產者更加重視安全性和透明的標籤。整體而言,新冠疫情加速了數位化銷售管道的發展,並提升了消費者對整體健康和增強自身韌性的關注。
預計在預測期內,維生素和礦物質細分市場將成為最大的細分市場。
由於消費者對其安全性的信任以及對微量營養素在甲狀腺、腎上腺和生殖功能中作用的認知,預計維生素和礦物質補充劑在預測期內將佔據最大的市場佔有率。處方醫生和藥劑師通常推薦這些補充劑,而且它們在包括藥局、超級市場和電商在內的各種零售管道均有銷售,從而推動了高銷售量。低廉的單位成本、成熟的生產能力和簡單的服用方法促進了重複購買。因此,預計該細分市場將保持其市場領先地位,而製造商正透過有針對性的配方和教育宣傳活動來推動其普及。
預計在預測期內,軟糖細分市場將實現最高的複合年成長率。
由於口感好、服用方便,軟糖品類預計將在預測期內達到最高成長率,吸引年輕消費者和不願服用藥丸的人。潔淨標示、無糖和質地豐富的配方提高了消費者的接受度,增加了重複購買率,同時也有助於堅持服用補充劑。醒目的口味和包裝提升了軟糖在零售店和線上的知名度。製造商們還推出了添加了維生素和植物成分的功能性軟糖,用於支持荷爾蒙平衡。這些優勢的綜合作用將推動軟糖品類的市場滲透,並帶來較高的複合年成長率。
預計北美在預測期內將佔據最大的市場佔有率,這主要得益於其先進的醫療保健基礎設施、消費者在健康方面的高支出以及高效營養補充劑的廣泛應用。豐富的零售和電商通路確保了產品的可近性,而監管則有助於提升產品品質和消費者信任度。臨床醫生的推薦和行銷正在推動荷爾蒙補充劑的普及。領先的本土生產商正加大研發投入並建立分銷夥伴關係,從而推出新的配方並擴大生產規模。這些因素共同作用,將助力北美在整個預測期內保持領先的市場佔有率。
預計亞太地區在預測期內將實現最高的複合年成長率,這主要得益於健康意識的提高、中等收入階層收入的成長以及電子商務的普及,使得營養補充劑更容易獲得。本土品牌和新興企業正在研發價格親民且符合當地文化的產品配方,而智慧型主導行銷則推動了消費者的試用和重複購買。政府營養計劃和不斷完善的分銷網路進一步促進了都市化人口的消費。這些人口、經濟和數位化因素的共同作用,正在推動亞太地區營養補充劑的快速普及。
According to Stratistics MRC, the Global Hormonal Balance Supplements Market is accounted for $3.8 billion in 2025 and is expected to reach $6.7 billion by 2032, growing at a CAGR of 8.1% during the forecast period. Hormonal balance supplements formulate botanicals, adaptogens, vitamins, minerals, and clinically researched compounds to support endocrine function, reproductive health, stress response, and metabolic regulation. Target consumers seek non-prescription, lifestyle-oriented approaches to symptom management and long-term wellness. Market expansion is driven by growing health awareness, demographic shifts, and broader screening for endocrine issues.
According to Mayo Clinic, consumer use of hormonal balance supplements such as phytoestrogen products has grown, with surveys indicating that 11% of adult women in the U.S. have used supplements for menopause or hormonal support.
Growing Awareness of Hormonal Health
Growing Awareness of Hormonal Health Growing public focus on hormonal wellbeing has driven demand for supplements addressing menstrual balance, menopause, thyroid support, and adrenal fatigue. Consumers seek preventive and corrective solutions, influenced by social media, influencers, and accessible health information. Medical practitioners increasingly suggest targeted nutraceuticals as adjuncts, while formulators develop evidence-informed blends and personalised dosages. Retail expansion, subscription models, and clearer labeling improve accessibility and trust, supporting steady market growth across demographics and distribution channels, with clinical research and quality assurance driving consumer confidence widely.
Lack of Strong Clinical Evidence
Lack of Strong Clinical Evidence Insufficient rigorous clinical trials and standardized dosage guidelines limit healthcare practitioner endorsement and institutional procurement of hormonal supplements. Many products rely on traditional uses or small-scale studies, creating ambiguity about effectiveness and safety across populations. This scientific gap hampers insurance coverage and large-scale clinical adoption, while regulators demand higher evidence standards. Consequently, consumer skepticism and cautious retailer listing slow market penetration.
Expansion into Men's Health
Expansion into Men's Health Targeting male hormonal health presents a significant growth avenue, addressing testosterone balance, libido, and age-related metabolic concerns. The category is broadening as men increasingly seek preventive wellness products and personalised regimens. Clinical messaging tailored to male physiology, discreet marketing channels, and male-oriented formulations such as capsules and gummies improve market receptivity. Partnerships with urologists and fitness professionals, along with workplace wellness programs, can drive adoption. Furthermore, rising awareness and demographic shifts amplify long-term demand and diversify revenue streams.
Counterfeit and Low-Quality Products
Counterfeit and Low-Quality Products Proliferation of counterfeit, adulterated, or substandard supplements undermines consumer trust and poses health risks, eroding legitimate market growth. Low-quality ingredients, mislabeling, and inconsistent manufacturing practices can lead to adverse events, product recalls, and legal actions that damage brand reputations. Retailers may tighten listing standards, and regulators may impose stricter oversight, increasing compliance costs.
The pandemic spurred rapid consumer adoption of supplements as people sought immune support and stress management, temporarily boosting sales across hormonal supplement categories. Supply chain disruptions caused short-term ingredient shortages and shifted sourcing strategies, while lockdowns encouraged ecommerce and direct-to-consumer models. Clinical research slowed but interest in preventive health rose, prompting manufacturers to emphasise safety and transparent labeling. Overall, COVID-19 accelerated digital sales channels and heightened consumer focus on holistic wellbeing and resilience.
The vitamins & minerals segment is expected to be the largest during the forecast period
The vitamins & minerals segment is expected to account for the largest market share during the forecast period because consumers trust their safety and recognise micronutrients' role in thyroid, adrenal, and reproductive function. Prescribers and pharmacists commonly recommend these supplements, and broad retail availability across pharmacies, supermarkets, and ecommerce drives high volumes. Low unit costs, established manufacturing capacity, and simple dosing encourage repeat purchases. Consequently, this segment sustains market leadership while enabling manufacturers to create targeted combination formulas and educational campaigns that boost adoption.
The gummies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gummies segment is predicted to witness the highest growth rate due to taste and ease of use, attracting younger consumers and pill-averse buyers. Clean-label, sugar-free, and textured formulations improve acceptability while supporting adherence to supplement regimens, increasing repeat purchases. Eye-catching flavours and packaging boost retail and online visibility. Manufacturers also launch functional gummy blends that combine vitamins and botanicals for hormonal support. Collectively, these advantages accelerate market penetration and result in higher compound annual growth rates for gummy formats.
During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure, high consumer spending on wellness, and strong supplement penetration. Broad retail and ecommerce channels ensure access, while regulatory oversight fosters product quality and consumer confidence. Clinician recommendations and marketing drive adoption of hormonal supplements. Large domestic manufacturers invest in R&D and form distribution partnerships, enabling new formulations and scale. These combined factors sustain North America's leading market share through the forecast period.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rising health awareness, growing middle-class incomes, and expanding ecommerce penetration that makes supplements widely accessible. Local brands and startups produce affordable, culturally relevant formulations, while smartphone-driven marketing accelerates trial and repeat purchases. Government nutrition programmes and improving distribution networks further support uptake across urbanising populations. Combined, these demographic, economic, and digital factors create a faster adoption curve in Asia Pacific
Key players in the market
Some of the key players in Hormonal Balance Supplements Market include Nature's Bounty Co., NOW Foods, Inc., Thorne Research, Inc., Garden of Life, LLC, Life Extension Foundation, Inc., Swanson Health Products, Inc., Herbalife Nutrition Ltd., Amway Corporation, GNC Holdings, LLC, Jarrow Formulas, Inc., Pure Encapsulations, LLC, MegaFood, LLC, Integrative Therapeutics, LLC, Himalaya Wellness Company, USANA Health Sciences, Inc., and Suntory Holdings Limited.
In June 2025, Nature's Bounty Co. launched "Advanced Menopause Relief", a plant-based, hormone-free dietary supplement designed for women in all stages of menopause. The product claims to help balance hormones and ease symptoms such as hot flashes, night sweats, low energy, anxiety and mood swings in one daily tablet.
In March 2025, Nature's Bounty shared new survey data showing that symptoms of menopause persist for many women and used this insight to support their product development in women's wellness and hormone-balance supplementation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.